| 14 May 2026 | TENDER | Apellis Pharmaceuticals, Inc. | 425,968 | — | |
| 14 May 2026 | TENDER | Apellis Pharmaceuticals, Inc. | 372,815 | — | |
| 14 May 2026 | TENDER | Apellis Pharmaceuticals, Inc. | 472,065 | — | |
| 14 May 2026 | TENDER | Apellis Pharmaceuticals, Inc. | 300,000 | — | |
| 14 May 2026 | TENDER | Apellis Pharmaceuticals, Inc. | 234,411 | — | |
| 14 May 2026 | GRANT_AWARD | Apellis Pharmaceuticals, Inc. | 143,750 | — | |
| 14 May 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 143,750 | — | |
| 14 May 2026 | GRANT_AWARD | Apellis Pharmaceuticals, Inc. | 87,108 | — | |
| 14 May 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 87,108 | — | |
| 14 May 2026 | GRANT_AWARD | Apellis Pharmaceuticals, Inc. | 97,976 | — | |
| 14 May 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 97,976 | — | |
| 14 May 2026 | GRANT_AWARD | Apellis Pharmaceuticals, Inc. | 195,952 | — | |
| 14 May 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 195,952 | — | |
| 14 May 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 20,862 | — | |
| 14 May 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 36,047 | — | |
| 14 May 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 97,997 | — | |
| 14 May 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 195,952 | — | |
| 14 May 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 100,538 | — | deriv |
| 14 May 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 273,779 | — | deriv |
| 14 May 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 287,500 | — | deriv |
| 14 May 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 273,312 | — | deriv |
| 14 May 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 170,400 | — | deriv |
| 14 May 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 206,250 | — | deriv |
| 14 May 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 150,000 | — | deriv |
| 14 May 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 131,093 | — | deriv |